Trial Profile
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 May 2022
Price :
$35
*
At a glance
- Drugs Pentoxifylline (Primary) ; Tocopherol (Primary)
- Indications Osteonecrosis
- Focus Therapeutic Use
- 26 Apr 2022 Planned End Date changed from 1 Jan 2023 to 30 Jun 2025.
- 26 Apr 2022 Planned primary completion date changed from 1 Jan 2022 to 1 Jan 2025.
- 01 May 2020 Planned End Date changed from 1 Jan 2020 to 1 Jan 2023.